Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dormoy

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The British Journal of Ophthalmology|November 22, 2005
Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiencyA Parissiadis, A Dormoy, D Fricker, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Class II alloantigen expression on leukemic cellsA Falkenrodt, A Urlacher, S Mayer, et al.
Pathologie-Biologie|May 31, 2014
Diagnosis and management of nocardiosis after bone marrow stem cell transplantation in adults: lack of lymphocyte recovery as a major contributing factorL Mansi, E Daguindau, P Saas, et al.
The Journal of Clinical Investigation|March 13, 1999
HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1H de la Salle, J Zimmer, D Fricker, et al.
Human Immunology|July 1, 1995
Reevaluation of the relative risk for susceptibility to celiac disease of HLA-DRB1, -DQA1, -DQB1, -DPB1, and -TAP2 alleles in a French populationA Meddeb-Garnaoui, D Zeliszewski, J F Mougenot, et al.
Tissue Antigens|April 21, 2007
Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantationsK Gagne, M Busson, M L Balere-Appert, et al.
Oncoimmunology|May 4, 2018
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trialO Adotevi, Y Godet, J Galaine, et al.
Bone Marrow Transplantation|June 9, 2016
Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI)P Rettman, F Malard, N Legrand, et al.
Bone Marrow Transplantation|November 4, 2014
Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective studyK Gagne, P Loiseau, V Dubois, et al.
International Journal of Immunogenetics|April 27, 2012
Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendationsA Sanchez-Mazas, B Vidan-Jeras, J M Nunes, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The British Journal of Ophthalmology|November 22, 2005
Unilateral necrotising toxoplasmic retinochoroiditis as the main clinical manifestation of a peptide transporter (TAP) deficiencyA Parissiadis, A Dormoy, D Fricker, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1989
Class II alloantigen expression on leukemic cellsA Falkenrodt, A Urlacher, S Mayer, et al.
Pathologie-Biologie|May 31, 2014
Diagnosis and management of nocardiosis after bone marrow stem cell transplantation in adults: lack of lymphocyte recovery as a major contributing factorL Mansi, E Daguindau, P Saas, et al.
The Journal of Clinical Investigation|March 13, 1999
HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1H de la Salle, J Zimmer, D Fricker, et al.
Human Immunology|July 1, 1995
Reevaluation of the relative risk for susceptibility to celiac disease of HLA-DRB1, -DQA1, -DQB1, -DPB1, and -TAP2 alleles in a French populationA Meddeb-Garnaoui, D Zeliszewski, J F Mougenot, et al.
Tissue Antigens|April 21, 2007
Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantationsK Gagne, M Busson, M L Balere-Appert, et al.
Oncoimmunology|May 4, 2018
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trialO Adotevi, Y Godet, J Galaine, et al.
Bone Marrow Transplantation|June 9, 2016
Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI)P Rettman, F Malard, N Legrand, et al.
Bone Marrow Transplantation|November 4, 2014
Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective studyK Gagne, P Loiseau, V Dubois, et al.
International Journal of Immunogenetics|April 27, 2012
Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendationsA Sanchez-Mazas, B Vidan-Jeras, J M Nunes, et al.
Pageof 3